MoonLake Immunotherapeutics (MLTX) Other Non-Current Assets (2023 - 2026)

MoonLake Immunotherapeutics' Other Non-Current Assets history runs 4 years deep, the most recent figure standing at $1.3 million for Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 20.85% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 20.85% decrease from a year earlier, with the FY2025 full-year figure at $596000.0, changed N/A from the prior year.
• Other Non-Current Assets improved to $1.3 million in Q1 2026 per MLTX's latest filing, from $596000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $8.4 million in Q4 2023 and bottomed at $587000.0 in Q3 2025.
• The 4-year median for Other Non-Current Assets is $1.7 million (2025), against an average of $3.0 million.
• Across the five-year window, Other Non-Current Assets plunged 73.13% in 2025 and slipped 20.85% in 2026, its largest moves.
• Year by year, Other Non-Current Assets stood at $8.4 million in 2023, then tumbled by 75.49% to $2.1 million in 2024, then slumped by 71.13% to $596000.0 in 2025, then jumped by 125.5% to $1.3 million in 2026.
• Per Business Quant, the three latest MLTX Other Non-Current Assets figures stand at $1.3 million (Q1 2026), $596000.0 (Q4 2025), and $587000.0 (Q3 2025).